news
WHO greenlights fractional yellow fever vaccine doses for kids
New research, including trials up to 2026, confirms that fractional doses (one-fifth of a vial) of the yellow fever vaccine are effective for infants and young children. This means existing vaccine stocks can protect more people in endemic areas, a strategy already endorsed by WHO for adults.
New research, including trials up to 2026, confirms that fractional doses (one-fifth of a vial) of the yellow fever vaccine are effective for infants and young children. This means existing vaccine stocks can protect more people in endemic areas, a strategy already endorsed by WHO for adults.
The architecture take
The WHO has been pushing fractional doses for a while now, primarily for adults, to stretch vaccine supplies during outbreaks. Now, with more data confirming it works for kids too, this shifts from an emergency measure to a standard protocol. It's about getting broader immunity into populations that need it most, without having to wait for manufacturing to catch up.
This isn't just about yellow fever; it's a template for future vaccine distribution strategy in low-resource settings. When manufacturing can't scale easily, you get smart with what you have. I'm watching to see which other vaccines adopt this approach, especially for diseases with limited production capacity. The real win here is for immunity at a population level, making every vial count for nervous systems under threat.